A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)

NCT00373529 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myelogenous Leukemia
Acute Myeloid Leukemia

Interventions

DRUG: clofarabine

Sponsor

Genzyme, a Sanofi Company